Cargando…
Seroprevalence of IgG Anti-SARS-CoV-2 among Voluntary Blood Donors in Dubai: Demographic and Risk Factors
BACKGROUND AND OBJECTIVES: During the pandemic of COVID-19, additional blood donor eligibility criteria have been added to ensure safety of donors and donations. The aim of this study is to estimate the seroprevalence of SARS-CoV-2 antibody in eligible donors and to study the demography and lifesty...
Autores principales: | Raouf, May, Rabeh, Mariem, Kaur, Suminder, Sharma, Ranjita, Thottumkal, Nimmy, Mohammed, Roukaya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8339022/ http://dx.doi.org/10.1159/000517456 |
Ejemplares similares
-
Analysis of blood donor pre-donation deferral in Dubai: characteristics and reasons
por: Al Shaer, Laila, et al.
Publicado: (2017) -
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
por: Uyoga, Sophie, et al.
Publicado: (2021) -
Ebola Virus IgG Seroprevalence in Southern Mali
por: Bane, Sidy, et al.
Publicado: (2021) -
The seroprevalence and kinetics of IgM and IgG in the progression of COVID-19
por: Qin, Xuzhen, et al.
Publicado: (2021) -
SEROPREVALENCE OF ERYTHROVIRUS B19 IgG AMONG SAUDI BLOOD DONORS IN MAKKAH, SAUDI ARABIA
por: Johargy, Ayman K.
Publicado: (2009)